Cardiovascular biomarkers better after metabolic surgery for diabetes
Improvements in markers of dyslipidaemia, inflammation, thrombosis and glycaemia, say authors
Cardiovascular biomarkers in people with type 2 diabetes improve more after metabolic surgery than with medical therapy, a US study shows.
Harvard University researchers compared 12 cardiovascular biomarkers after up to five years in 100 patients with type 2 diabetes and a BMI between 27-43kg/m2.